Cambridge Investment Research Advisors’s Ginkgo Bioworks DNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-864
| Closed | -$12K | – | 3438 |
|
|
2024
Q2 | $12K | Sell |
864
-93
| -10% | -$1.29K | ﹤0.01% | 3284 |
|
|
2024
Q1 | $44K | Buy |
957
+13
| +1% | +$598 | ﹤0.01% | 3223 |
|
|
2023
Q4 | $64K | Buy |
944
+44
| +5% | +$2.98K | ﹤0.01% | 3085 |
|
|
2023
Q3 | $65K | Buy |
900
+12
| +1% | +$867 | ﹤0.01% | 3015 |
|
|
2023
Q2 | $66K | Buy |
888
+4
| +0.5% | +$297 | ﹤0.01% | 3060 |
|
|
2023
Q1 | $47K | Buy |
884
+53
| +6% | +$2.82K | ﹤0.01% | 3039 |
|
|
2022
Q4 | $56K | Buy |
831
+481
| +137% | +$32.4K | ﹤0.01% | 2969 |
|
|
2022
Q3 | $44K | Buy |
+350
| New | +$44K | ﹤0.01% | 2951 |
|
|
2022
Q2 | – | Sell |
-265
| Closed | -$43K | – | 3091 |
|
|
2022
Q1 | $43K | Buy |
+265
| New | +$43K | ﹤0.01% | 3085 |
|